What is the mechanism of action of Ebvallo?
•
4 min read
Over half of all relapsed or refractory EBV+ PTLD cases after initial treatment have poor outcomes and limited therapeutic options, highlighting a significant unmet medical need. **What is the mechanism of action of Ebvallo?** Ebvallo is an allogeneic, off-the-shelf T-cell immunotherapy that directly addresses this by selectively targeting and eliminating EBV-infected cells.